Skipping Hormone Therapy in Low-Risk Early Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Breast Cancer (Early Breast Cancer)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Ico Angers, Angers, France

    Contact: Study coordinator (Dr PATSOURIS)
  • Sainte Catherine, Institut du Cancer Avignon-Provence, Avignon, France

    Contact: Study coordinator (Dr GRENIER)
  • CH Aunay-Bayeux, Bayeux, France

    Contact: Study coordinator (Dr BRACHET)
  • CHCB, Bayonne, France

    Contact: Study coordinator (Dr GRELLETY)
  • Clinique Tivoli, Bordeaux, France

    Contact: Study coordinator (Dr GARBAY)
  • Institut Bergonié, Bordeaux, France

    Contact: Study coordinator (Dr PETIT)
  • CH Boulogne sur mer, Boulogne-sur-Mer, France

    Contact: Study coordinator (Dr DESGROUSILLIERS)
  • Clinique Pasteur Lanroze, Brest, France

    Contact: Study coordinator (Dr LENGLET)
  • CH de Bligny, Briis-sous-Forges, France

    Contact: Study coordinator (Dr MERIC)
  • Centre Francois Baclesse, Caen, France

    Contact: Study coordinator (Dr EMILE)
  • Pole Sante Leonard de Vinci- Roc37, Chambray-lès-Tours, France

    Contact: Study coordinator (Dr BERNADOU)
  • Centre Jean Perrin, Clermont-Ferrand, France

    Contact: Study coordinator (Dr MOURET-REYNIER)
  • Centre Leonard de Vinci, Dechy, France

    Contact: Study coordinator (Dr ESCANDE)
  • Centre Georges François Leclerc, Dijon, France

    Contact: Study coordinator (Pr LADOIRE)
  • CH Annecy Genevois, Épagny, France

  • CHD Vendée, La Roche-sur-Yon, France

    Contact: Study coordinator (Dr LEGOUTE)
  • Centre Guillaume le Conquérant, Le Havre, France

  • Centre Oscar Lambret, Lille, France

  • CHU de Limoges, Limoges, France

    Contact: Study coordinator (Pr DELUCHE)
  • Groupe Hospitalier Bretagne Sud, Lorient, France

    Contact: Study coordinator (Dr BERTHET)
  • Centre Léon Bérard, Lyon, France

  • Hôpital privé Jean Mermoz, Lyon, France

    Contact: Study coordinator (Dr DERBEL)
  • Hôpital Privé Clairval, Marseille, France

    Contact: Study coordinator (Dr PAOLI)
  • Institut Paoli-Calmettes, Marseille, France

    Contact: Study coordinator (Pr GONCALVES)
  • CHI de Mont-de-Marsan, Mont-de-Marsan, France

  • Centre Antoine Lacassagne, Nice, France

    Contact: Study coordinator (Dr GROULIER)
  • CHU Orleans, Orléans, France

    Contact: Study coordinator (Dr TOROSSIAN)
  • CHP Sainte Marie, Osny, France

    Contact: Study coordinator (Dr BLEICHNER)
  • Groupe Hospitalier Paris Saint Joseph, Paris, France

    Contact: Study coordinator (Dr SIMONAGGIO)
  • Institut Curie, Paris, France

  • Centre Eugène Marquis, Rennes, France

    Contact: Study coordinator (Dr PERRIN)
  • Centre Henri Becquerel, Rouen, France

    Contact: Study coordinator (Dr VITUCCI)
  • Institut Curie, Saint-Cloud, France

    Contact: Study coordinator (Dr BELLO ROUFAI)
  • Ico Saint Herblain, Saint-Herblain, France

    Contact: Study coordinator (Dr FRENEL)
  • CHU de Saint Etienne, Saint-Priest-en-Jarez, France

    Contact: Study coordinator (Dr CORSINI)
  • Centre de lutte contre le cancer - Paul Strauss, Strasbourg, France

    Contact: Study coordinator (Dr BISCHOFF)
  • Hôpitaux du Léman, Thonon-les-Bains, France

    Contact: Study coordinator (Dr CIOBANU)
  • IUCT-Oncopole, Toulouse, France

    Contact: Study coordinator (Pr DALENC)
  • CHU Tours, Tours, France

    Contact: Study coordinator (Dr LARRIVIERE)
  • Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France

    Contact: Study coordinator (Dr CHARRA-BRUNAUD)
  • Groupe UNEOS-Hôpital Robert Schuman, Vantoux, France

    Contact: Study coordinator (Dr BENNA)
Study leads
  • Jean-Yves PIERGA, MD

    Principal Investigator

    Institut Curie

  • José Luis SANDOVAL, MD

    Principal Investigator

    University Hospital, Geneva